A signaling molecule called interleukin-6 may be a therapeutic target to prevent vision loss or nerve degeneration in glaucoma, Vanderbilt researchers have discovered.

Renewal House and Vanderbilt University Medical Center (VUMC) have launched an alliance that will expedite treatment and expand the community’s capacity to treat mothers and children most acutely affected by opioid addiction in the mid-state.

Monroe Carell Jr. Children’s Hospital at Vanderbilt’s Pediatric Pulmonary Hypertension (PH) program has earned the top level of accreditation from the national Pulmonary Hypertension Association (PHA).

Vanderbilt investigators have conducted a first-of-its-kind genome-wide association study of lung cancer survival in African-Americans.

Two national disability-related organizations representing professionals and families are recognizing the accomplishments of three Vanderbilt Kennedy Center members.